Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients

被引:0
|
作者
Jiun, Tan Wan [1 ]
Taib, Haslina [2 ,6 ]
Mohamad, Wan Majdiah Wan [3 ]
Mohamad, Suharni [4 ]
Ghazali, Wan Syamimee Wan [5 ]
机构
[1] Klinik Pergigian Cahaya Suria, Unit Periodontik, 7 Jalan 3-12, Kuala Lumpur 50050, Malaysia
[2] Univ Sains Malaysia, Sch Dent Sci, Periodont Unit, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[3] Hlth Campus Univ Sains Malaysia, Sch Dent Sci, Immunol Unit, Kota Baharu 16150, Kelantan, Malaysia
[4] Univ Sains Malaysia, Sch Dent Sci, Microbiol Unit, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[5] Univ Sains Malaysia, Sch Med Sci, Med Dept, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[6] Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
关键词
Porphyromonas gingivalis; Periodontitis; Rheumatoid arthritis; Anti -cyclic citrullinated peptide; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; TREPONEMA-DENTICOLA; DISEASE; ACTINOMYCETEMCOMITANS; ASSOCIATION; PARAMETERS; SEVERITY;
D O I
10.1016/j.intimp.2023.110940
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Porphyromonas gingivalis (P. gingivalis) is the primary periodontal pathogen involved in protein citrullination, which triggers the production of anti-cyclic citrullinated peptide (anti-CCP) antibodies, exacerbating rheumatoid arthritis (RA). This study aims to evaluate the amount of P. gingivalis and its association with anti-CCP antibodies in RA patients with periodontitis. This cross-sectional study involves 100 RA patients with a mean age of 52.36 (SD 13.90) years. Smokers and patients with other uncontrolled systemic diseases were excluded. Disease Ac-tivity Score-28 (DAS-28) was used to determine RA disease severity. Periodontal parameters were examined to determine periodontal status. Subsequently, plaque samples were collected from the subgingival periodontal pocket for assessment of P. gingivalis bacterial load using the loop-mediated isothermal amplification method. Blood samples (5 ml) were obtained from all participants to analyse anti-CCP antibody levels. Data was analysed by using SPSS version 24.0. Most participants were female (85.0%) and had low RA disease severity (62%). The mean RA disease duration was 7.77 (SD 6.3) years, with a mean DAS-28 of 3.17 (SD 1.0). Forty-seven per cent of participants had periodontitis, but all periodontal parameters were not associated with RA disease activity (P = 0.38). P. gingivalis bacterial load ranged from 10 to 109 copies/mu l. Fifty-five per cent of the collected samples showed positive anti-CCP antibody levels, but no significant association was observed with the P. gingivalis bacterial load (P = 0.58). Considering the study's limitations, although periodontitis is prevalent among RA patients, there is a lack of association between P. gingivalis bacterial load and anti-CCP antibody levels, which should be investigated further.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
    Mohamad, Wan Majdiah Wan
    Jia, Soh Ke
    Ghazali, Wan Syamimee Wan
    Taib, Haslina
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2018, 34 (04) : 907 - 912
  • [2] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [3] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [4] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
  • [5] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    V Michael Holers
    Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
  • [6] Anti-cyclic citrullinated peptide antibodies in juvenile rheumatoid arthritis patients.
    Moore, TL
    Chung, AK
    Kietz, DA
    Pepmueller, PH
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S338 - S338
  • [7] Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Mofidi, Mani
    Moghadam, Afshin
    SAUDI MEDICAL JOURNAL, 2008, 29 (08) : 1206 - 1207
  • [8] Anti-cyclic citrullinated peptide antibodies in elderly onset rheumatoid arthritis
    Riccieri, V.
    Macri, V.
    Germano, V.
    Vasile, M.
    Sciarra, I.
    Scrivo, R.
    Spadaro, A.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 300 - 300
  • [9] Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Sghiri, Rim
    Bouagina, Elyes
    Zaglaoui, Hela
    Mestiri, Hajer
    Harzallah, Latifa
    Harrabi, Imed
    Ghannouchi, Mehdi
    Mokhtar, Faycel
    Ghedira, Ibtissem
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (12) : 1125 - 1130
  • [10] Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Rim Sghiri
    Elyes Bouagina
    Hela Zaglaoui
    Hajer Mestiri
    Latifa Harzallah
    Imed Harrabi
    Mehdi Ghannouchi
    Faycel Mokhtar
    Ibtissem Ghedira
    Rheumatology International, 2007, 27 : 1125 - 1130